Pandemic

August 9th 2023

Report on lessons from crisis includes—and ignites—some criticism.

January 30th 2023

Agency panel backs the use of a common bivalent shot for all patients.

August 11th 2020

Should therapies and vaccines be cheap or free in a pandemic and would that really dry up innovation?

August 10th 2020

In adjusting to the long-term aftershocks from the coronavirus pandemic, pharma companies will need to focus on change in three core areas.